Lipid-lowering therapy in low-risk patients.
- 27 May 1998
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 279 (20) , 1659-1661
- https://doi.org/10.1001/jama.279.20.1659
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Antiatherothrombotic properties of statins. Implications for cardiovascular event reductionJournal of Cardiothoracic and Vascular Anesthesia, 1999
- Baseline Risk Factors and their Association With Outcome in the West of Scotland Coronary Prevention StudyThe American Journal of Cardiology, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels: The Regression Growth Evaluation Statin Study (REGRESS)ACC Current Journal Review, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Kuopio Atherosclerosis Prevention Study (KAPS)Circulation, 1995
- Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)The American Journal of Cardiology, 1995
- Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS)Annals of Internal Medicine, 1993
- An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reductionThe American Journal of Cardiology, 1991
- Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemiaJAMA, 1988